cohort 1 litespark-003: belzutifan cabozantinib 1l treatment for advanced rcc
Published 1 year ago • 256 plays • Length 1:05Download video MP4
Download video MP3
Similar videos
-
1:20
promising results of cabozantinib plus nivolumab in non-clear cell rcc
-
1:40
phase iii meteor trial: cabozantinib vs everolimus for advanced clear cell renal cell carcinoma
-
0:54
phase ib/ii trial of 177lu-girentuximab with cabozantinib and nivolumab in clear cell rcc
-
2:32
unanswered questions of interest from the litespark-004 trial
-
5:05
cabozantinib plus atezolizumab for non-clear cell renal cell carcinoma
-
1:48
what is the best second-line treatment of advanced renal cell carcinoma (rcc)?
-
3:01
david a. braun, md, phd, discusses the preliminary analysis of belzutifan cabozantinib in ccrcc
-
7:08
final analysis of the atlantis cabozantinib comparison
-
13:17
belzutifan for von hippel-lindau syndrome
-
5:42
meteor trial: cabozantinib vs everolimus in advanced renal cell carcinoma
-
4:02
atezolizumab plus bevacizumab in non-clear cell, sarcomatoid kidney cancer
-
7:17
cabozantinib in renal cell carcinoma
-
1:04
dr. wei on the use of cabozantinib in advanced kidney cancer
-
1:16
dr. ezra cohen discusses the cabozantinib dose size and tolerability
-
1:19
otelixizumab
-
1:49
scleral multifocals - patient testamonial
-
2:01
analysis of cell cycle position in mammalian cells l protocol preview
-
0:19
zeiss celldiscoverer 7: hela kyoto cells, 48 hours time-lapse fluorescence microscopy